BRIEF published on 05/12/2025 at 17:40, 6 months 23 days ago Biotest confirme ses prévisions pour 2025 malgré une baisse de son chiffre d'affaires Biotest AG Baisse Des Revenus Risques Du Marché Collaboration Grifols Orientations 2025
BRIEF published on 05/12/2025 at 17:40, 6 months 23 days ago Biotest Confirms 2025 Guidance Amid Revenue Decline Revenue Decline Biotest AG Market Risks 2025 Guidance Grifols Collaboration
PRESS RELEASE published on 05/12/2025 at 17:35, 6 months 23 days ago Biotest confirms Guidance for 2025 Biotest confirms sales guidance for 2025 despite first quarter revenue decrease. EBIT decline attributed to lower sales and earnings from technology services Sales EBIT Guidance 2025 Biotest
BRIEF published on 03/31/2025 at 08:45, 8 months 5 days ago Biotest AG annonce sa radiation de la cote et une offre publique d'achat Grifols SA Biotest AG Bourse De Francfort Accord De Radiation Offre Aux Actionnaires
BRIEF published on 03/31/2025 at 08:45, 8 months 5 days ago Biotest AG Announces Delisting and Tender Offer Frankfurt Stock Exchange Grifols S.A. Biotest AG Shareholder Offer Delisting Agreement
PRESS RELEASE published on 03/31/2025 at 08:40, 8 months 5 days ago EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer Biotest AG has concluded a delisting agreement with major shareholder Grifols, S.A., initiating a delisting tender offer for its shares. The offer aims at revoking stock exchange admission Stock Exchange Tender Offer Biotest AG Delisting Agreement Grifols
BRIEF published on 03/31/2025 at 07:05, 8 months 5 days ago Biotest AG Sees 6% Sales Increase in 2024 Biotest AG 2025 Outlook 2024 Sales Yimmugo® Approval Fibrinogen Application
BRIEF published on 03/31/2025 at 07:05, 8 months 5 days ago Biotest AG prévoit une augmentation de ses ventes de 6 % en 2024 Biotest AG Perspectives 2025 Ventes 2024 Approbation Yimmugo® Application Du Fibrinogène
PRESS RELEASE published on 03/31/2025 at 07:00, 8 months 5 days ago Biotest AG increases sales by 6% in financial year 2024 Biotest AG reports 6% sales growth in 2024 financial year, achieving upper end of EBIT guidance. Significant approval milestones reached for key products Financial Report Sales Growth Biotest AG EBIT Guidance Approval Milestones
BRIEF published on 03/06/2025 at 09:06, 8 months 30 days ago Biotest AG's CFO Martin Möller to Depart Pharmaceuticals CFO Departure Biotest AG Grifols Group Martin Möller
Published on 12/05/2025 at 15:00, 16 minutes ago Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 16 minutes ago Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 16 minutes ago Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 41 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 15:05, 11 minutes ago Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 53 minutes ago EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 59 minutes ago Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 6 minutes ago The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 31 minutes ago BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 15:10, 5 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 17 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 31 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 31 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
